| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
adenosine kinase | 0.584 | 0.769 | 3.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1999 | 2001 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
adenosine A1 receptor | 0.578 | 0.692 | 1.5E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
adrenoceptor alpha 2A | 0.578 | 0.615 | 8.2E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
adrenoceptor alpha 2C | 0.682 | 0.346 | 0.50 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
phenotype | 0.210 | None | 0.500 | 1 | 0 | 2009 | 2017 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.540 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
anoctamin 3 | 0.716 | 0.385 | 1.2E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 1997 | 2019 | ||||||||
|
aquaporin 4 | 0.456 | 0.885 | 2.3E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
beta-secretase 1 | 0.559 | 0.769 | 0.88 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 1999 | 2010 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.290 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
beclin 1 | 0.432 | 0.846 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
calcium voltage-gated channel subunit alpha1 B | 0.650 | 0.577 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
calcium voltage-gated channel subunit alpha1 I | 0.792 | 0.231 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
phenotype | 0.540 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
calcium/calmodulin dependent protein kinase II alpha | 0.612 | 0.538 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2010 | ||||||||
|
calpain 2 | 0.590 | 0.692 | 3.5E-22 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 |